GeneTex
United States (US)

SLC25A21 antibody

SLC25A21-antibody-GTX87583-WB-1_18122102_965.jpg
SLC25A21-antibody-GTX87583-IHC-1_18122102_733.jpg

Cat No. GTX87583

Host Rabbit
Clonality Polyclonal
Application WB, IHC-P, ELISA
Reactivity Human, Mouse, Rat
APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
WB Assay dependent
IHC-P Assay dependent
ELISA Assay dependent
Not tested in other applications.

Calculated MW

33 kDa. ( Note )

Specificity/Sensitivity

SLC25A21 Antibody detects endogenous levels of total SLC25A21 protein.
PROPERTIES

Form

Liquid

Buffer

Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Antigen Species

Human

Immunogen

The antiserum was produced against synthesized peptide derived from human SLC25A21.

Purification

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Conjugation

Unconjugated

Note

For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

SLC25A21, Solute carrier family 25 member 21, Solute carrier family25 member21, Mitochondrial 2oxodicarboxylate carrier, Mitochondrial 2-oxodicarboxylate carrier, Mitochondrial2oxodicarboxylate carrier

Background

Transports C5-C7 oxodicarboxylates across the inner membranes of mitochondria. Can transport 2-oxoadipate, 2-oxoglutarate, adipate, glutarate, and to a lesser extent, pimelate, 2-oxopimelate, 2-aminoadipate, oxaloacetate, and citrate.
Show More +

Database

Research Area

DATA IMAGES
SLC25A21-antibody-GTX87583-WB-1_18122102_965.jpg

GTX87583 WB Image

Western blot analysis of extracts from HepG2 cells, using SLC25A21 Antibody. The lane on the right is treated with the synthesized peptide.

SLC25A21-antibody-GTX87583-IHC-1_18122102_733.jpg

GTX87583 IHC-P Image

Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue, using SLC25A21 Antibody. The picture on the right is treated with the synthesized peptide.